Concepedia

Rasim Gucalp

RG

Statistics

Publications

40

Citations

2.1K

H-Index

25

Active since

1990

Affiliations

Albert Einstein College of Medicine(Current)

Montefiore Medical Center

National University Hospital

Chang Gung Memorial Hospital

University of Ljubljana

Rasim Gucalp is an author at Albert Einstein College of Medicine specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1990–2023

40

Publications

40

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma.

Michael B. Atkins, Joseph A. Sparano, Richard I. Fisher et al. · Journal of Clinical Oncology · 1993 · 219 citations

, , +17

Denosumab for Treatment of Hypercalcemia of Malignancy

Mimi I. Hu, Ilya Glezerman, Sophie Leboulleux et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 200 citations · Full text

, , +16

Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.

Rasim Gucalp, Paul S. Ritch, P H Wiernik et al. · Journal of Clinical Oncology · 1992 · 151 citations

, , +10

Sequential treatment with afatinib and osimertinib in patients with <i>EGFR</i> mutation-positive non-small-cell lung cancer: an observational study

Maximilian J. Hochmair, Alessandro Morabito, Desirée Hao et al. · Future Oncology · 2018 · 97 citations · Full text

, , +9

Sequential Afatinib and Osimertinib in Patients with <i>EGFR</i> Mutation-Positive Non-Small-Cell Lung Cancer: Updated Analysis of the Observational Giotag Study

Maximilian J. Hochmair, Alessandro Morabito, Desirée Hao et al. · Future Oncology · 2019 · 82 citations · Full text

, , +11

1–5 of 40